Janux Therapeutics, Inc. (JANX) stock
JANXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3037% below fair value
$10.71−0.21 (-1.92%)
Close on Nov 17, 2026Market cap $654.78MP/E –Yield –
Janux Therapeutics gross margin
Gross margin is gross profit as a percentage of revenue.
No gross margin figures for Janux Therapeutics
Janux Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?